Sunesis Pharmaceuticals
From Wikipedia, the free encyclopedia
 |
The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. Please help to establish notability by adding reliable, secondary sources about the topic. If notability cannot be established, the article is likely to be merged, redirected, or deleted. (March 2011) |
Sunesis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of small molecular therapeutics for oncology and other unmet medical needs. The company was founded by Jim Wells[1],[2].
Founded in 1998, Sunesis filed and completed an IPO in 2005. It is listed on NASDAQ as SNSS. [1]
[edit] External links
[edit] References
 |
This United States corporation or company article is a stub. You can help Wikipedia by expanding it. |
